Guidelines NMB
Back to course
Video Transcription
Video Summary
Keywords
neuromuscular blocking agents
monitoring considerations
Sugammadex
reversal
objective monitoring
train-of-four ratio
neostigmine
end-stage renal disease
comorbidities
 
AANA white logo
10275 W. Higgins Rd., Suite 500, Rosemont, IL 60018
Phone: 847-692-7050
 
AANA® is a registered trademark of the American Association of Nurse Anesthesiology. Privacy policy. Copyright © 2023 American Association of Nurse Anesthesiology. All rights reserved.
Android App Download IOS App Download Powered By